An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10-17 years of age
Keywords: یکسوساز کنترلشده با سیلیکون; AEs; adverse events; CBER; Center for Biologics Evaluation & Research; CHMP; Committee for Medicinal Products for Human Use; CI; confidence interval; GMFR; geometric mean fold rise; GMT; geometric mean titer; HA; hemagglutinin; HI; hemagglutination inhibi